<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741180</url>
  </required_header>
  <id_info>
    <org_study_id>15-00116</org_study_id>
    <nct_id>NCT02741180</nct_id>
  </id_info>
  <brief_title>Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias</brief_title>
  <official_title>Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to improve the quality of Magnetic Resonance Imaging in
      patients with heart arrhythmia. Investigators will recruit 105 patients with arrhythmia and
      30 control volunteers over 3 years and will use two arrhythmia-tolerant imaging methods for
      diagnosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the proposed research, investigators will extend conventional cardiac magnetic resonance
      methods to enable the creation of high-quality cine CMR images in the presence of multiple
      kinds of arrhythmia. Two arrhythmia-tolerant imaging methods will be adopted, which are
      particularly useful in arrhythmia: 1) 3D imaging, which is useful for many purposes,
      including &quot;road mapping&quot; of electrophysiology (EP) procedures, and 2) late gadolinium
      enhancement (LGE), which is useful for delineating abnormal myocardium, including fibrotic
      regions that can serve as sources of arrhythmias.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paired-sample Wilcoxon signed rank test to evaluate measures on Likert scales</measure>
    <time_frame>3 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Paired-sample t tests for quantitative measures of intensity of image artifacts</measure>
    <time_frame>3 Years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Cardiac Arrythmias</condition>
  <arm_group>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3D Imaging</intervention_name>
    <description>&quot;roadmapping&quot; of electrophysiology (EP) procedures</description>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
    <arm_group_label>Healthy Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Late Gadolinium Enhancement (LGE)</intervention_name>
    <description>useful for delineating abnormal myocardium, including fibrotic regions that can serve as sources of arrhythmias.</description>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
    <arm_group_label>Healthy Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Arrhythmia Patients:

          -  Patients diagnosed with heart arrhythmia scheduled for routine clinical MRI
             examinations).

          -  Patients scheduled for routine clinical MRI examinations who do not have a specific
             known diagnosis of arrhythmia, but who may be found to have image degradation due to
             arrhythmia during the CMR examination.

        Inclusion Criteria for Controls:

          -  No history of heart arrhythmia.

        Exclusion Criteria for Patients and Controls:

          -  Hemodynamic instability.

          -  Contraindications for MRI examinations (e.g., pacemakers or ferromagnetic vascular
             clips).

          -  History of prior cardiovascular disease or significant risk factors:

               -  Diabetes, hypertension, smoking, and hyperlipidemia, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leon Axel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriella Maranga</last_name>
    <email>Gabrielle.Maranga@nyumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthew Lustberg</last_name>
    <email>lustbm01@nyumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriella Maranga</last_name>
      <email>Gabrielle.Maranga@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Mathew Lustberg</last_name>
      <email>lustbm01@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Leon Axel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

